NCT03727763 2021-08-19Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)Shanghai Changzheng HospitalPhase 2 Unknown30 enrolled